ArticleFrontiers in oncology2021

Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia.

Gunjan Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.